Research reveals GLP-1 agonist agent lixisenatide presenting perspective of treating Parkinson disease and encouraging investigations in its efficacy and safety profiles. ...
Research reveals GLP-1 agonist agent lixisenatide presenting perspective of treating Parkinson disease and encouraging investigations in its efficacy and safety profiles. ...
Join our subscribers list to get the latest news, updates and special offers delivered directly in your inbox.